Quadrant Capital Group’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Quadrant Capital Group’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-565	Closed	-$15.3K	–	2803
2024 Q2	$15.3K	Buy	565 +46	+9%	+$957	﹤0.01%	1966
2024 Q1	$9.51K	Hold	519	–	–	﹤0.01%	2126
2023 Q4	$6.37K	Buy	519 +462	+811%	+$4.33K	﹤0.01%	2207
2023 Q3	$855	Sell	57 -16	-22%	-$333	﹤0.01%	2508
2023 Q2	$2.37K	Buy	73 +58	+387%	+$2.12K	﹤0.01%	2379
2023 Q1	$587	Hold	15	–	–	﹤0.01%	2585
2022 Q4	$793	Buy	15 +2	+15%	+$97	﹤0.01%	2577
2022 Q3	$1K	Buy	13 +12	+1,200%	+$516	﹤0.01%	2594
2022 Q2	$0	Sell	1 -12	-92%	-$436	﹤0.01%	2793
2022 Q1	$1K	Buy	+13	New	+$458	﹤0.01%	2432
2021 Q4	–	Sell	-11	Closed	-$1K	–	2737
2021 Q3	$1K	Buy	+11	New	+$576	﹤0.01%	2426

Other funds holding SILK

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Quadrant Capital Group's SILK Position: Q3 2024 in Review

Quadrant Capital Group sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 565 shares — an estimated $15.3K sold.

Quadrant Capital Group first reported a position in SILK in Q3 2021 and held it in 11 quarters. The position peaked at $15.3K in Q2 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

Quadrant Capital Group reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Quadrant Capital Group sold 565 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $15.3K.
Quadrant Capital Group first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
Quadrant Capital Group's Silk Road Medical, Inc. Common Stock position peaked at $15.3K in Q2 2024.
1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Quadrant Capital Group's 13F filing for Q3 2024, filed 12 Nov 2024.